A new malaria vaccine achieves an unparalleled 89% efficacy by targeting late-liver-stage antigens, unlocking new horizons in the fight against global disease. Study: Safety and Efficacy of ...

For the malaria parasite to reach the blood of its human host, it must first enter the liver, where only a small number of parasites differentiate and replicate for upwards of seven days, making it a ...

The malaria parasite must first enter the liver to reach the blood of its human host, where only a small number of parasites differentiate and replicate for upwards of seven days, making it a ...

New research has uncovered that Leishmania parasites engage in widespread genetic exchange, overturning assumptions of primarily clonal reproduction, while malaria parasites deploy mRNA to disrupt ...

Researchers studying the malaria parasite Plasmodium falciparum have discovered a previously unknown stage in its life cycle that appears to be crucial for reproduction. This is important because ...

Please provide your email address to receive an email when new articles are posted on . In a human challenge trial, the GA2 vaccine prevented 89% of people who received it from being infected with ...

Progress in the eradication of malaria has slowed, creating a need for new tools. Immunization with a genetically attenuated parasite arresting late in the liver stage may improve protection. New ...

At a World Malaria Day symposium, experts called for stronger surveillance, cross-border coordination and sustained commitment to keep India on track for malaria elimination by 2030.